Omnivision develops semiconductor solutions, including advanced digital imaging and touch display technology. The companies plan to integrate Omnivision’s CameraCubeChip into EndoQuest’s flexible surgical robotic system.
Houston-based EndoQuest designed its system to address unmet needs in gastrointestinal and other endoluminal surgeries. It offers precision and flexibility to improve patient outcomes. The proprietary technology navigates and performs procedures within the body’s lumina spaces, allowing for minimally invasive interventions.
The platform makes it possible for therapeutic endoscopists and surgeons to operate through a trans-oral or trans-anal approach. EndoQuest raised $42 million to support the platform last month. Earlier this week, the FDA’s Safer Technologies Program (STeP) accepted the flexible surgical robotic system.
Omnivision designed its CameraCubeChip as a visualization solution with its PureCel Plus-S pixel technology. It enables high full-well capacity, zero blooming and lower power consumption with crisp, clear, life-like images. The compact, medical-grade offering could take patient care and surgical visualization “to the next level,” the companies say.
“We are excited to be able to incorporate Omnivision’s market-leading sensor technology into the visualization component of our first-of-its-kind platform,” said Kurt Azarbarzin, CEO of EndoQuest Robotics. “We recognize that advanced imaging is essential to enhancing physician capabilities, especially inside the lumen of the gastrointestinal (GI) tract. Omnivision’s newest technology is ideal for our flexible robotic system.”
